Anti-cancer Activity of Anthricin through Caspase-dependent Apoptosis in Human Hypopharyngeal Squamous Carcinoma Cell
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Anthricin (Deoxypodophyllotoxin), a naturally occurring flavolignan, has well known anti-cancer properties in several cancer cells, such as prostate cancer, cervical carcinoma and pancreatic cancer. However, the effects of Anthricin are currently unknown in oral cancer. We examined the anticancer effect and mechanism of action of Anthricin in human FaDu hypopharyngeal squamous carcinoma cells. Our data showed that Anthricin inhibits cell viability in a dose- and time-dependent manner (IC50 50 nM) in the MTT assay and Live & Dead assay. In addition, Anthricin treated FaDu cells showed marked apoptosis by DAPI stain and FACS. Furthermore, Anthricin activates anti-apoptotic factors such as caspase-3, -9 and poly (ADP-ribose) polymerase (PARP), suggesting that caspase-mediated pathways are involved in Anthricin- induced apoptosis. Anthricin treatment also leads to accumulation of the pro-apoptotic factor Bax, followed by inhibition of cell growth. Taken together, these results indicate that Anthricn-induced cell death of human FaDu hypopharyngeal squamous carcinoma cells is mediated by mitochondrial-dependent apoptotic pathway. In summary, our findings provide a framework for further exploration on Anthricin as a novel chemotherapeutic drug for human oral cancer.
Abstract
Anthricin (Deoxypodophyllotoxin), a naturally occurring flavolignan, has well known anti-cancer properties in several cancer cells, such as prostate cancer, cervical carcinoma and pancreatic cancer. However, the effects of Anthricin are currently unknown in oral cancer. We examined the anticancer effect and mechanism of action of Anthricin in human FaDu hypopharyngeal squamous carcinoma cells. Our data showed that Anthricin inhibits cell viability in a dose- and time-dependent manner (IC50 50 nM) in the MTT assay and Live & Dead assay. In addition, Anthricin treated FaDu cells showed marked apoptosis by DAPI stain and FACS. Furthermore, Anthricin activates anti-apoptotic factors such as caspase-3, -9 and poly (ADP-ribose) polymerase (PARP), suggesting that caspase-mediated pathways are involved in Anthricin- induced apoptosis. Anthricin treatment also leads to accumulation of the pro-apoptotic factor Bax, followed by inhibition of cell growth. Taken together, these results indicate that Anthricn-induced cell death of human FaDu hypopharyngeal squamous carcinoma cells is mediated by mitochondrial-dependent apoptotic pathway. In summary, our findings provide a framework for further exploration on Anthricin as a novel chemotherapeutic drug for human oral cancer.
참고문헌 (19)
- Greenlee RT, "Cancer statistics", CA Cancer J Clin, 51, pp.15~36 (2001)
- Daniele Maggioni, "Flavonoids in oral cancer prevention and therapy", European Journal of Cancer Prevention, 24(6), pp.517~528 (2015), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Hopper C, "mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma", Int J Cancer, 111, pp.138~146 (2004)
- Synytsya A, "Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii structure and potential prebiotic activity", Carbohydr Polym, pp.021~ (2008)[DOI]
- Yeonjoong Yong, "Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus sylvestris: Induction of G2", M cell cycle arrest and caspase-dependent apoptosis, 2009, pp.19(15), 4367~4371[DOI]
- Ikeda R, "Antiproliferative constituents in umbelliferae plants. III. Constituents in the root and the ground part of Anthriscus sylvestris Hoffm", Chem Pharm Bull (Tokyo), 46, pp.871~874 (1998)
- Yong Kim, "Deoxypodophyllotoxin; The Cytotoxic and Antiangiogenic Component from Pulsatilla koreana", Planta Medica, 68(3), pp.271~274 (2002), Thieme Publishing Group[DOI]
- Lin CX, "Deoxypodophyllotoxin, a Naturally Occurring Lignan, inhibits the Passive Cutaneous Anaphylaxis Reaction", Planta Medica, 70(5), pp.474~476 (2004), Thieme Publishing Group[DOI]
- Kwang-Youn Kim, "Interplay of reactive oxygen species, intracellular Ca(2+)surge and loss of mitochondrial homeostasis in the apoptotic ablation of prostate cancer cells by deoxypodophyllotoxin", Journal of Cellular Biochemistry, 114(5), pp.1124~1134 (2013), Wiley-Blackwell[DOI]
- Soon Young Shin, "Deoxypodophyllotoxin induces G2", M cell cycle arrest and apoptosis in HeLa cells, 2010, pp.287(2), 231~239[DOI]
- Jeong GS, "Lignans and coumarins from the roots of Anthriscus sylvestris and their increase of caspase-3 activity in HL-60cells", Biol Pharm Bull, 30, pp.1340~1343 (2007)
- Kweon Sang Moon, "Therapeutic Effects of SB Natural Anticancer Drug in 50 Patients with Stage IV Pancreatic Cancer", Journal of Cancer Treatment and Research, 3(3), pp.42~ (2015), Science Publishing Group[DOI]
- Wang Y, "Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio", Oncotarget (2015), Impact Journals, LLC[DOI]
- Yeung-Leung Cheng, "Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo", Cancer Letters, 222(2), pp.183~193 (2005), Elsevier BV[DOI]
- Park DI, "Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiforum in human lung carcinama cells", Pharmacol Res, 51, pp.437~443 (2005)[DOI]
- Lee SH, "Dual inhibition of cyclooxygenase-2and 5-lipoxynenase by deoxypodophyllotoxin in mouse bone marrow-derived mast cells", Biol Pharm Bull, 27, pp.786~788 (2004)
- Yu-Rong Wang, "Deoxypodophyllotoxin Induces G2", M Cell Cycle Arrest and Apoptosis in SGC-7901 Cells and Inhibits Tumor Growth in Vivo, 2015, pp.20(1), 1661~1675[DOI]
- Jung CH, "Anthricin Isolated from Anthriscus sylvestris (L.) Hoffm. inhibits the growth of Breast cancer cells by inhibiting Akt", mTOR signaling, and its apoptosis effects are enhanced by autophagy inhibition, 2013, pp.2013, 9~
- Chun-Yan Sang, "DPMA, a deoxypodophyllotoxin derivative, induces apoptosis and anti-angiogenesis in non-small cell lung cancer A549 cells", Bioorganic & Medicinal Chemistry Letters, 23(24), pp.6650~6655 (2013), Elsevier BV[DOI]